Cephalosporins' Cross-Reactivity and the High Degree of Required Knowledge. Case Report and Review of the Literature.

R1 side-chain R2 side-chain anaphylactic shock cefepime ceftriaxone immunohistochemistry liability medical malpractice

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
25 Apr 2020
Historique:
received: 02 04 2020
revised: 14 04 2020
accepted: 23 04 2020
entrez: 30 4 2020
pubmed: 30 4 2020
medline: 30 4 2020
Statut: epublish

Résumé

Antibiotic cross-reactivity represents a phenomenon of considerable interest as well as antibiotic resistance. Immediate reactions to cephalosporins are reported in the literature with a prevalence of only 1%-3% of the population, while anaphylactic reactions are rarely described (approximately 0.0001%-0.1%) as well as fatalities. Allergic reaction to cephalosporins may occur because of sensitization to unique cephalosporin haptens or to determinants shared with penicillins. Cross-reactivity between cephalosporins represents, in fact, a well-known threatening event involving cephalosporins with similar or identical R1- or R2-side chains. The present report describes the case of a 79-year-old man who suddenly died after intramuscular administration of ceftriaxone. Serum dosage of mast cell tryptase from a femoral blood sample at 3 and 24 hours detected values of 87.7μg/L and 93.5μg/L, respectively (cut-off value 44.3 μg/L); the serum-specific IgE for penicillins, amoxicillin, cephaclor and also for the most common allergens were also determined. A complete post-mortem examination was performed, including gross, histological and immunohistochemical examination, with an anti-tryptase antibody. The cause of death was identified as anaphylactic shock: past administrations of cefepime sensitized the subject to cephalosporins and a fatal cross-reactivity of ceftriaxone with cefepime occurred due to the identical seven-position side chain structure in both molecules. The reported case offers food for thought regarding the study of cross-reactivity and the need to clarify the predictability and preventability of the phenomenon in fatal events.

Identifiants

pubmed: 32344946
pii: antibiotics9050209
doi: 10.3390/antibiotics9050209
pmc: PMC7277108
pii:
doi:

Types de publication

Case Reports

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Pharmacotherapy. 2004 May;24(5):668-72
pubmed: 15162902
Curr Pharm Biotechnol. 2019;20(8):625-634
pubmed: 30961487
Clin Exp Allergy. 2015 Feb;45(2):300-27
pubmed: 25623506
Ann Intern Med. 2004 Jul 6;141(1):16-22
pubmed: 15238366
J Mol Recognit. 2003 May-Jun;16(3):148-56
pubmed: 12833570
J Allergy Clin Immunol. 2000 Dec;106(6):1177-83
pubmed: 11112903
Clin Exp Allergy. 2002 Nov;32(11):1644-50
pubmed: 12569987
J Allergy Clin Immunol. 2006 Feb;117(2):404-10
pubmed: 16461141
Lancet. 2019 Jan 12;393(10167):183-198
pubmed: 30558872
J Allergy Clin Immunol. 2015 Nov;136(5):1426-8
pubmed: 26388313
Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):13S-18S
pubmed: 17349459
Intern Med J. 2019 Aug;49(8):985-993
pubmed: 30667130
Ann Allergy Asthma Immunol. 2014 May;112(5):404-12
pubmed: 24767695
Int Forum Allergy Rhinol. 2015 Feb;5(2):104-10
pubmed: 25332200
N Engl J Med. 2001 Sep 13;345(11):804-9
pubmed: 11556301
Br J Clin Pharmacol. 2011 May;71(5):684-700
pubmed: 21480948
J Mol Recognit. 1996 Jul-Aug;9(4):287-96
pubmed: 9131470
J Allergy Clin Immunol. 2015 Mar;135(3):745-52.e5
pubmed: 25262461
Clin Rev Allergy Immunol. 2013 Aug;45(1):131-42
pubmed: 23546989
Curr Pharm Biotechnol. 2017;18(3):274-281
pubmed: 28176638
Allergy. 2005 Dec;60(12):1545-6
pubmed: 16266391
Int Arch Allergy Appl Immunol. 1990;92(4):439-44
pubmed: 2083978
J Allergy Clin Immunol. 2004 May;113(5):832-6
pubmed: 15131563
Clin Exp Allergy. 2005 Sep;35(9):1234-42
pubmed: 16164453
Curr Pharm Biotechnol. 2017;18(3):194-203
pubmed: 28240172
J Allergy Clin Immunol. 2016 Apr;137(4):1148-1153
pubmed: 26688516
Curr Pharm Biotechnol. 2017;18(3):263-273
pubmed: 28176637
Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-273
pubmed: 20934625
Sci Rep. 2018 Aug 24;8(1):12811
pubmed: 30143737
Allergy. 2018 Sep;73(9):1833-1841
pubmed: 29517808
Clin Exp Allergy. 2001 Mar;31(3):438-43
pubmed: 11260156
Curr Pharm Biotechnol. 2019;20(8):643-652
pubmed: 30961489
J Fam Pract. 2006 Feb;55(2):106-12
pubmed: 16451776
J Allergy Clin Immunol. 2015 Sep;136(3):685-691.e3
pubmed: 25930196
Allergy Asthma Proc. 2004 Jan-Feb;25(1):23-6
pubmed: 15055557
Immunol Allergy Clin North Am. 2004 Aug;24(3):463-76, vi-vii
pubmed: 15242721
Allergy. 2016 Sep;71(9):1305-13
pubmed: 26970431
J Allergy Clin Immunol. 2014 Mar;133(3):790-6
pubmed: 24188976
Qual Saf Health Care. 2004 Aug;13(4):306-14
pubmed: 15289635
JAMA. 1966 Oct 24;198(4):345-8
pubmed: 5953252
Ann Allergy Asthma Immunol. 2018 Nov;121(5):530-536
pubmed: 29551402
Allergy. 2003 Jun;58(6):537-8
pubmed: 12757464
Curr Pharm Des. 2006;12(26):3335-45
pubmed: 17017928
Curr Pharm Biotechnol. 2017;18(3):242-252
pubmed: 28183244
Chem Res Toxicol. 2011 May 16;24(5):706-17
pubmed: 21425867
Pharmacy (Basel). 2019 Jul 29;7(3):
pubmed: 31362351
Allergy. 2004 Feb;59(2):239-41
pubmed: 14763949
Curr Allergy Asthma Rep. 2016 Mar;16(3):24
pubmed: 26898316
PLoS One. 2016 Jul 20;11(7):e0159406
pubmed: 27438379
Allergy. 2010 Jan;65(1):130-1
pubmed: 20078505
Clin Exp Allergy. 2011 Nov;41(11):1602-8
pubmed: 22093010
Pediatrics. 2005 Apr;115(4):1048-57
pubmed: 15805383
Clin Infect Dis. 2015 Sep 1;61(5):741-9
pubmed: 25991471
Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):297-300
pubmed: 12130943
J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1532-1542
pubmed: 28843343
J Allergy Clin Immunol. 2012 Dec;130(6):1442-2.e5
pubmed: 23195529

Auteurs

Stefano D'Errico (S)

Department of Medicine, Surgery and Health, University of Trieste, 34149 Trieste, Italy.

Paola Frati (P)

Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Martina Zanon (M)

Department of Medicine, Surgery and Health, University of Trieste, 34149 Trieste, Italy.

Eleonora Valentinuz (E)

Department of Medicine, Surgery and Health, University of Trieste, 34149 Trieste, Italy.

Federico Manetti (F)

Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Matteo Scopetti (M)

Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Alessandro Santurro (A)

Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Vittorio Fineschi (V)

Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Classifications MeSH